HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation

Bone Marrow Transplant. 2020 Aug;55(8):1658-1661. doi: 10.1038/s41409-020-0827-3. Epub 2020 Feb 13.

B Grønvold¹, M M Ali², M Remberger^{2

3}, J Mattsson⁴, T Egeland^{5

6}, K U Lundin⁵, A E Myhre², I W Abrahamsen², D Heldal², I Dybedal², G E Tjønnfjord^{2

6}, Y Fløisand^#^{2

7}, T Gedde-Dahl^#^{2

6}

¹ Department of Haematology, Oslo University Hospital, Oslo, Norway. bjoegr@ous-hf.no.
² Department of Haematology, Oslo University Hospital, Oslo, Norway.
³ Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden.
⁴ Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
⁵ Institute of Immunology, Oslo University Hospital, Oslo, Norway.
⁶ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁷ Centre for Cancer Cell Reprogramming, Department of Molecular Cell Biology, Oslo University Hospital, Oslo, Norway.

^# Contributed equally.

No abstract available

Publication types